Inactive

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to BioRad Inc, to obtain Pertussis FHA and Pertussis Fimbriae Antibodies. The MPIR Immunob... The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to BioRad Inc, to obtain Pertussis FHA and Pertussis Fimbriae Antibodies. The MPIR Immunobiology laboratory is working on assay development for the detection of Pertussis antigen. In order to create an antigen detection assay, monoclonal recombinant antibodies need to be obtained. This will be done by using bacterial toxin derived from Bordetella Pertussis and a cell surface protein of Bordetella Pertussis. These two monoclonal recombinant antibodies will be generated through means of HuCAL technology for the purpose of using these antibodies to perform in-vitro research studies. Pertussis FHA and Pertussis Fimbriae antibodies are needed to capture and detect the disease causing pertussis antigen. The Fimbriae monoclonal recombinant antibodies should recognize the bacterial toxin derived from Bordetella Pertussis, and the FHA monoclonal recombinant antibodies should recognize a cell surface protein of the Bordetella pertussis. As additional specification, the antibodies shall not recognize Closely Related Antigens or Cross-Reactive Antigens (CRAs). This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at Qrz9@cdc.gov by 12:00pm 11 September, 2023.

Inactive

This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The Center for Disease Control and Prevention (CDC) is seeking information on a potential ... This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The Center for Disease Control and Prevention (CDC) is seeking information on a potential requirement for “Pertussis FHA and Pertussis Fimbriae Antibodies” with the following requirements: The contractor must be able to produce Pertussis FHA and Pertussis Fimbriae monoclonal recombinant antibodies using the HuCAL technology. The purpose of this notice is to obtain information regarding the availability and capability of qualified suppliers. Responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. Contract Type: Firm Fixed price Capability statement/information sought: Respondents who believe that they possess the capability to meet the government’s needs as described above are invited to submit capabilities addressing those requirements and examples of prior completed Government contracts, references, and other related information. Respondent must indicate in your capability statement: Organization name Address UEI number Inidcation if the concern is a manufacturer or nonmanufacturer Business size Classification pursuant to the applicable NAICS code of 325414 –Biological Product (except Diagnostic) Manufacturing, And Related Services size standard Points of contact Email Telephone number Details of similar experience as explained above. Page Limitation: 10 pages. Response Due Date: Submit information above to Kourtney Marshall, Contract Specialist, qrz9@cdc.gov. Reference: #77861. Responses are due no later than 12:00 pm, Sept 6, 2023 Eastern Time. Any information received by the government will not be returned. Disclaimer and Important Notes. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization’s qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be posted on Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. Confidentiality. No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).